Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBodycote Regulatory News (BOY)

Share Price Information for Bodycote (BOY)

Share Price is delayed by 15 minutes
Get Live Data
702.50    -1.00 (-0.14%)
Bid:
699.00
Ask:
700.00
Spread: 1.00 (0.143%)
Market Cap: £1.20b
BOY Live PriceLast checked at - London Stock Exchange

Intraday Bodycote Share Chart

Divisional re-statement for enhanced Optimise programme

18 Nov 2025 07:05

Bodycote Plc - Divisional re-statement for enhanced Optimise programme

Bodycote Plc - Divisional re-statement for enhanced Optimise programme

PR Newswire

LONDON, United Kingdom, November 18

18 November 2025

Bodycote plc

Divisional re-statement for enhanced Optimise programme

 

 

Bodycote, the world's leading provider of specialist thermal processing services, today publishes historical financial information for 2024 and the first half of 2025 reflecting a new divisional reporting structure.

 

At our Half Year results on 30 July 2025 we announced an expansion to the scope of our ongoing Optimise programme. The revised and final programme, which includes 30 plants, will deliver an improved run-rate profit benefit of at least £15m by mid-2027 for a net cash cost of £10-15m. As a result of this expanded scope, the additional plants will now be classified as Non-Core. Our Full Year 2025 results will be presented based on this updated structure.

 

The tables below show our H1 2024, FY 2024 and H1 2025 divisional performance on the new re-classified basis. The historical financial information contained in the following tables is unaudited.

 

 

Half year to 30 June 2025

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

£m

£m

£m

£m

£m

£m

Revenue

104.5

232.1

-

336.6

32.4

369.0

Adjusted operating profit/(loss)

27.2

34.9

(8.6)

53.5

1.6

55.1

Return on sales

26.0%

15.0%

 

15.9%

4.9%

14.9%

 

 

 

Half year to 30 June 2024

 

 

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

£m

£m

£m

£m

£m

£m

Revenue

115.3

243.0

-

358.3

40.7

399.0

Adjusted operating profit/(loss)

34.4

40.4

(10.2)

64.6

2.2

66.8

Return on sales

29.8%

16.6%

 

18.0%

5.4%

16.7%

 

 

 

2024 FY

 

 

Specialist Technologies

Precision Heat Treatment

Central costs and eliminations

Total Core

Non-Core

Total Group

£m

£m

£m

£m

£m

£m

Revenue

222.3

459.8

-

682.1

75.0

757.1

Adjusted operating profit/(loss)

65.5

80.4

(20.4)

125.5

3.5

129.0

Return on sales

29.5%

17.5%

 

18.4%

4.7%

17.0%

 

 

 

 

 

 

For further information, please contact:

 

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Investor Relations and FP&A

Tel: +44 1625 505 300

 

Disclosures:

This announcement contains forward-looking statements based on current expectations and assumptions. Various known and unknown risks, uncertainties and other factors may cause actual results to differ from future results or developments expressed or implied from the forward-looking statements. Each forward-looking statement speaks only as of the date of this document. Bodycote plc accepts no obligation to revise or update these forward-looking statements publicly or adjust them to future events or developments, whether as a result of new information, future events or otherwise, except to the extent legally required.

 



Date   Source Headline
14th Feb 20193:44 pmPRNHolding(s) in Company
12th Feb 20194:21 pmPRNHolding(s) in Company
31st Jan 20195:00 pmPRNTotal Voting Rights
4th Jan 20195:25 pmPRNTotal Voting Rights
18th Dec 20184:50 pmRNSHolding(s) in Company
30th Nov 20185:00 pmPRNTotal Voting Rights
15th Nov 20187:00 amRNSTrading Update
5th Nov 20181:03 pmPRNExternal Board Appointment
31st Oct 20185:00 pmPRNTotal Voting Rights
29th Oct 20184:09 pmRNSHolding(s) in Company
18th Oct 20189:30 amPRNHolding(s) in Company
11th Oct 20184:42 pmPRNDirector/PDMR Shareholding
28th Sep 20184:30 pmPRNTotal Voting Rights
18th Sep 20182:07 pmRNSHolding(s) in Company
7th Sep 20183:10 pmPRNDirector/PDMR Shareholding
31st Aug 20185:00 pmPRNTotal Voting Rights
16th Aug 201810:42 amPRNHolding(s) in Company
13th Aug 201810:27 amRNSHolding(s) in Company
31st Jul 20185:00 pmPRNTotal Voting Rights
27th Jul 20185:11 pmPRNHolding(s) in Company
26th Jul 20187:00 amRNSResults for the six months to 30 June 2018
17th Jul 20187:00 amRNSBODYCOTE TO OPEN NEW HEAT TREATMENT FACILITY IN UK
9th Jul 20185:07 pmRNSHolding(s) in Company
3rd Jul 201810:02 amPRNHolding(s) in Company
3rd Jul 20189:36 amPRNHolding(s) in Company
29th Jun 20185:00 pmPRNTotal Voting Rights
7th Jun 20184:49 pmPRNDirector/PDMR Shareholding
31st May 20185:00 pmPRNTotal Voting Rights
30th May 20181:10 pmRNSResult of AGM
30th May 20187:00 amRNSTrading Update
22nd May 20185:10 pmPRNChange in Director's Particulars
21st May 201812:49 pmPRNHolding(s) in Company
17th May 201812:36 pmPRNHolding(s) in Company
14th May 20184:53 pmPRNHolding(s) in Company
23rd Apr 20185:41 pmPRNDirector/PDMR Shareholding
23rd Apr 20182:50 pmPRNGrant of deferred bonus share award
18th Apr 20182:00 pmPRNChanges in Director's Particulars
18th Apr 20187:00 amRNS15-year contract with Rolls-Royce
12th Apr 201811:33 amPRNDirector/PDMR Shareholding
29th Mar 20186:00 pmPRNTotal Voting Rights
29th Mar 20189:00 amPRNAnnual Financial Report
7th Mar 201812:11 pmPRNChanges in Director's Particulars
6th Mar 201811:47 amPRNDirector/PDMR Shareholding
6th Mar 20187:00 amRNSFinal Results
28th Feb 20185:00 pmPRNTotal Voting Rights
20th Feb 20187:00 amRNSBODYCOTE ENTERS INTO AGREEMENT WITH SAFRAN
12th Feb 20185:30 pmPRNChanges in Director's Particulars
12th Feb 20182:43 pmPRNNotification of Change of Registrar
31st Jan 20185:00 pmPRNTotal Voting Rights
24th Jan 20187:00 amRNSEuropean Expansion in Hot Isostatic Pressing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.